1. Home
  2. Investing
  3. Stocks
  4. USA
  6. BeiGene Ltd (BGNE)
  7. News


BeiGene News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BeiGene Ltd BGNE NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-3.82 -1.09% 347.69 17:00:00
Open Price Low Price High Price Close Price Prev Close
350.15 340.00 353.99 347.69 351.51
more quote information »

Recent News

Date Time Source Heading
11/24/202104:17SEEKBeiGene's Brukinsa OK'd in Europe for Waldenström’s..
11/23/202117:21EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/23/202117:10EDGARCurrent Report Filing (8-k)
11/23/202117:00BWBeiGene Announces Approval of BRUKINSA (zanubrutinib) in the..
11/23/202108:17SEEKBeiGene purchases N.J. site for manufacturing, R&D center
11/23/202108:15BWBeiGene Launches Proposed Initial Public Offering on the..
11/23/202107:00BWBeiGene Closes on Property for New U.S. Manufacturing and..
11/22/202109:06SEEKBeiGene initiates first-in-human Phase 1 trial of TYK2..
11/22/202107:00BWBeiGene Initiates First-in-Human Phase 1 Clinical Trial of..
11/19/202118:19EDGARStatement of Changes in Beneficial Ownership (4)
11/16/202109:08EDGARCurrent Report Filing (8-k)
11/14/202119:00BWBeiGene and NewBridge Pharmaceuticals Announce Approval in..
11/10/202117:31EDGARStatement of Changes in Beneficial Ownership (4)
11/10/202117:26EDGARStatement of Changes in Beneficial Ownership (4)
11/04/202117:26SEEKBeiGene EPS beats by $0.58, beats on revenue
11/04/202116:49EDGARQuarterly Report (10-q)
11/04/202116:24EDGARCurrent Report Filing (8-k)
11/04/202116:05BWBeiGene Reports Third Quarter 2021 Financial Results
11/04/202109:00BWBeiGene to Present Clinical Data on BRUKINSA in Chronic..
10/21/202117:38EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202116:20EDGARCurrent Report Filing (8-k)
10/20/202107:00BWBeiGene and Nanolek Announce Approval in Russia for..
10/13/202117:28EDGARCurrent Report Filing (8-k)
10/10/202117:00BWBeiGene Announces BRUKINSA® (Zanubrutinib) Approved for..
10/07/202116:13SEEKBeiGene's inhibitor gets a nod from Australia for treating..
10/07/202116:06BWBeiGene Announces First Regulatory Approval in Australia for..
10/07/202116:05BWBeiGene Announces First Regulatory Approval in Australia for..
9/21/202110:57BWATTENTION - RECTIFICATION : BeiGene a reçu un avis favorable..
9/20/202116:29EDGARCurrent Report Filing (8-k)
9/20/202107:00BWBeiGene Announces Inclusion in FTSE Russell Indices
9/17/202109:06BWBeiGene a reçu un avis favorable du Comité des médicaments à..
9/17/202108:50DJNBeiGene Gets CHMP Backing of Brukinsa in Waldenstrom's..
9/17/202108:00BWBeiGene Receives Positive CHMP Opinion for BRUKINSA®..
9/16/202118:07EDGARStatement of Changes in Beneficial Ownership (4)
9/16/202105:35SEEKLeap Therapeutics stock jumps 47% on positive DKN-01 +..
9/15/202118:16EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202107:00BWU.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated..
9/13/202108:17DJNLeap Therapeutics Sees Positive Data for Trial of Cancer..
9/13/202100:00BWBeiGene Announces U.S. FDA Acceptance of Biologics License..
9/12/202118:05BWBeiGene to Present Latest Findings in Robust Lung Cancer..
9/02/202116:21EDGARCurrent Report Filing (8-k)
9/01/202117:33BWU.S. FDA Grants BRUKINSA® (Zanubrutinib) Approval in..
8/26/202116:22EDGARCurrent Report Filing (8-k)
8/26/202101:46SEEKHutchmed initiates mid-stage fruquintinib combo study in..
8/24/202116:32EDGARCurrent Report Filing (8-k)
8/22/202119:00BWBeiGene Announces Acceptance of a Supplemental Biologics..
8/19/202116:35EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.